In this post I link to and excerpt from Dr Josh Farkas’ Internet Book Of Critical Care [Link is to the TOC] Inhaled Pulmonary Vasodilators of August 8, 2020. [Link is to the podcast.] Dr Farkas writes in his introduction:
Inhaled pulmonary vasodilators are generally quite safe. They offer a variety of physiologic benefits to patients with cardiopulmonary failure, including improved oxygenation and right ventricular function. Unfortunately, like so many interventions in critical care, there is a dearth of large, multi-center RCTs proving patient-centered benefit. This chapter attempts to sift through available evidence, in efforts to use these agents in a rational fashion.
[Each of the links below are direct links to that section of the IBCC podcast and show notes.]
CONTENTS
- Physiologic effects
- Specific agents
- Contraindications & adverse effects
- Indications
- Summary table
- Podcast
- Questions & discussion
- Pitfalls
- PDF of this chapter (or create customized PDF)